Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Sales | 7,224 | 0 | 8,818 |
| Gross Profit | 7,224 | N/A | 8,818 |
| Operating Expenses | 71,336 | 0 | 56,972 |
| Operating Income | -64,112 | N/A | -48,154 |
| Interest Expense | 182 | 0 | 368 |
| Other Income | 2,608 | 0 | 4,264 |
| Pre-tax Income | -61,686 | 0 | -44,258 |
| Income Tax | 28 | N/A | 56 |
| Net Income Continuous | -61,714 | N/A | -44,314 |
| Minority Interests | -268 | N/A | -2,629 |
| Net Income | $-61,446 | $N/A | $-41,685 |
| EPS Basic Total Ops | -1.07 | N/A | -1.62 |
| EPS Basic Continuous Ops | -0.95 | N/A | -1.35 |
| EPS Diluted Total Ops | -1.07 | N/A | -1.62 |
| EPS Diluted Continuous Ops | -0.95 | N/A | -1.35 |
| EBITDA(a) | $-60,985 | $N/A | $-45,659 |